“One Arm and One Leg”: The Insurance Warrior’s Battle Plan

Can’t see the audio player? Click here to listen.

Click here for a transcript of the episode.

Matthew Lientz was an engineer at Boeing for over 30 years. When diagnosed with a rare form of cancer, he had to be operated on by an expert doctor from another state. Although surgery was his only option, his insurance denied the claim. It was then that his wife, Diane, contacted Laurie Todd, who calls herself the “insurance warrior”.

Together, the three of them pleaded for Lientz’s life. Fourteen years later, the speeches they’ve given in a boardroom filled with executives are a master class for earning insurance calls – and living to tell the story.

Through this battle, Todd learned that going after your health insurance provider often means going against your employer. This is because most large companies are “self-insuring”.

And in this case, this employer was one of the biggest companies in the world.

For the origin story of “Insurance Warrior,” check out our previous episode.

“An Arm and a Leg” is a KHN and Public Road Productions co-production.

To stay in touch with “One Arm and One Leg”, subscribe to the newsletter. You can also follow the show on Facebook and Twitter. And if you have any healthcare system stories to tell, the producers would love to hear from you.

To listen to all of KHN’s podcasts, click here.

And subscribe to “An Arm and a Leg” on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you listen to podcasts.

We encourage organizations to republish our content, for free. Here’s what we’re asking for:

You must credit us as the original publisher, with a hyperlink to our khn.org site. If possible, please include the original author (s) and “Kaiser Health News” in the signature. Please keep the hyperlinks in the story.

It is important to note that not everything on khn.org is available for republishing. If a story is tagged “All rights reserved”, we cannot grant permission to repost that item.

Have questions? Let us know at [email protected]

Comments are closed.